Glooko announced today that it secured $100 million in a financing round and appointed Mike Alvarez as its new CEO.

Clearside Biomedical today announced that the ODYSSEY study of its drug-device combination achieved its primary and secondary ...

Injection delivery system developer ApiJect announced that it promoted Molly Weaver to the position of chief operating ...

Trinity Biotech today announced that it completed the first pre-pivotal clinical trial in Europe for its next-generation CGM ...

The National Institutes of Health (NIH) launched a nationwide consortium to address the rise in youth diagnosed with type 2 ...

BD (NYSE:BDX) announced today that it entered into a collaboration with ten23 health to develop a new way to track ...

Medinol today announced the successful first-in-human implantation of its ChampioNIR drug-eluting peripheral stent.

MannKind announced top-level 30-week results from its Phase 4 INHALE-3 study comparing inhaled insulin to traditional ...

Ascensia Diabetes Care announced today that it launched the Eversense 365 CGM system from Senseonics (NYSE:SENS) ...

Eyenovia (Nasdaq:EYEN) announced that it began manufacturing batches of its Mydcombi product for its next-generation delivery ...

Qnovia’s nicotine replacement therapy device. [Image courtesy of Qnovia] Qnovia announced that the FDA cleared its investigational new drug (IND) application for the RespiRx smoking cessation inhaler ...